Mononucleosis News and Research

RSS
How Epstein-Barr virus shapes immune responses in multiple sclerosis

How Epstein-Barr virus shapes immune responses in multiple sclerosis

Study finds Epstein-Barr virus T-cells prevalent in early multiple sclerosis

Study finds Epstein-Barr virus T-cells prevalent in early multiple sclerosis

Research shows how the immune system keeps Herpes simplex virus at bay

Research shows how the immune system keeps Herpes simplex virus at bay

Researchers announce a new genetic classification system for gastric cancer

Researchers announce a new genetic classification system for gastric cancer

Unveiling the role of EBV in the onset and progression of multiple sclerosis

Unveiling the role of EBV in the onset and progression of multiple sclerosis

Novel multi-epitope subunit vaccine induces robust immune response against Epstein-Barr virus

Novel multi-epitope subunit vaccine induces robust immune response against Epstein-Barr virus

Unraveling the Epstein-Barr virus enigma: The puzzling role in multiple sclerosis development

Unraveling the Epstein-Barr virus enigma: The puzzling role in multiple sclerosis development

Researchers show how the EBV virus exploits genomic weaknesses to cause cancer

Researchers show how the EBV virus exploits genomic weaknesses to cause cancer

Study suggests psychosocial factors, not acute infections, contribute to long-COVID in young adults

Study suggests psychosocial factors, not acute infections, contribute to long-COVID in young adults

MedUni Vienna researchers identify specific immune response to Epstein-Barr virus

MedUni Vienna researchers identify specific immune response to Epstein-Barr virus

SARS-CoV-2 infection triggers reactivation of latent viruses in people with chronic fatigue syndrome

SARS-CoV-2 infection triggers reactivation of latent viruses in people with chronic fatigue syndrome

Study shows the potential of experimental monoclonal antibodies to treat Epstein-Barr virus infection

Study shows the potential of experimental monoclonal antibodies to treat Epstein-Barr virus infection

Why fatigue from long COVID goes beyond simply feeling tired

Why fatigue from long COVID goes beyond simply feeling tired

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

Multiple sclerosis may be caused by infection with the Epstein-Barr virus

Multiple sclerosis may be caused by infection with the Epstein-Barr virus

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

Red blood cell distribution width as a biomarker for COVID-19

Red blood cell distribution width as a biomarker for COVID-19

Study findings could lead to novel ways to overcome tumor resistance to immunotherapies

Study findings could lead to novel ways to overcome tumor resistance to immunotherapies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.